Jan 24, 2019 / 01:30PM GMT
Operator
Good day, and welcome to the Bristol-Myers Squibb 2018 Fourth Quarter Results Conference Call. Today's conference is being recorded.
At this time, I would like to turn the conference over to Mr. John Elicker, Senior Vice President, Public Affairs and Investor Relations. Please go ahead, sir.
John E. Elicker - Bristol-Myers Squibb Company - SVP of Corporate Affairs & IR
Thank you, Greg, and good morning, everyone, and thanks for joining the call today. We do have a lot to discuss, including the quarter, our full year results, 2019 outlook as well as some additional perspectives on our announced acquisition of Celgene. We will be using a slide deck today, so we did e-mail it to you about 15 minutes ago. The slides are also available on our website.
Joining me today with prepared remarks are Giovanni Caforio, our Chairman and CEO; Charlie Bancroft, our CFO; and Chris Boerner, our Chief Commercial Officer. Tom Lynch is our Chief Scientific Officer, will also be here for Q&A. You'll see on Slides 2 and 3 of today's presentation our legal
Q4 2018 Bristol-Myers Squibb Co Earnings Call Transcript
Jan 24, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers